CVE-2024-31096: Kopatheme Nictitate

Medium severity, CVSS 4.3. EPSS: 0.2% chance of exploitation in the next 30 days.

Cross-Site Request Forgery (CSRF) vulnerability in kopatheme Nictitate.This issue affects Nictitate: from n/a through 1.1.4.

Affected products

• Kopatheme Nictitate: up to and including 1.1.4

Published 2024-03-31. Last modified 2026-06-17.